ID

42141

Beschrijving

Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01907763

Link

https://clinicaltrials.gov/show/NCT01907763

Trefwoorden

Versies (4)
  1. 30-03-16 30-03-16 -
  2. 30-03-16 30-03-16 - Julian Varghese
  3. 30-03-16 30-03-16 - Julian Varghese
  4. 13-04-21 13-04-21 - Dr. rer. medic Philipp Neuhaus
Geüploaded op

13 april 2021

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Asthma NCT01907763

Engels

Eligibility Asthma NCT01907763

1 Formulieren  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01907763
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. male or eligible female subjects aged 15 years or more
Beschrijving

Age | Gender

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0079399
2. a female is eligible if she is of:
Beschrijving

Female | eligible

Datatype

boolean

non-child bearing potential (i.e., physiologically incapable of becoming pregnant), including any female who is at least 2 year after post- menopausal
Beschrijving

Incapable | Pregnancy | Postmenopausal state

Datatype

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2]
C0232970
child bearing potential and agrees to the acceptable contraceptive methods used consistently and correctly
Beschrijving

Childbearing Potential | Contraceptive methods

Datatype

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0680240
negative pregnancy test at screening
Beschrijving

Pregnancy test negative

Datatype

boolean

Alias
UMLS CUI [1]
C0427780
3. non-smoker for at least 1 year, a pack history of ≤ 10 pack years
Beschrijving

Non-smoker | pack-years history

Datatype

boolean

Alias
UMLS CUI [1,1]
C0337672
UMLS CUI [1,2]
C2230126
4. symptom of persistent asthma, as defined by the national institute of health (nih) 5.50 percent ≤ fev1 ≤ 80 percent predicted at screening visit (withholding inhaled, short acting
Beschrijving

Persistent asthma | FEV1

Datatype

boolean

Alias
UMLS CUI [1,1]
C3266628
UMLS CUI [1,2]
C0748133
ß-agonist for 6 hours)
Beschrijving

Adrenergic beta-Agonists

Datatype

boolean

Alias
UMLS CUI [1]
C0001644
6.fev1 reversibility ≥ 12 percent and 200 ml at 20-30 minutes after inhalation of a short acting
Beschrijving

FEV1 | Reversibility

Datatype

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C0449261
ß-agonist (salbutamol 2 puffs; 200㎍) at visit 1 or within 6 months before visit 1 7.capable of withholding salbutamol use for ≥ 6 hours prior to clinic visits 8.appropriately signed and dated informed consent has been obtained
Beschrijving

Adrenergic beta-Agonists | Salbutamol

Datatype

boolean

Alias
UMLS CUI [1,1]
C0001644
UMLS CUI [1,2]
C0001927
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. active upper or lower respiratory tract infection within 3 weeks before visit 1
Beschrijving

Upper Respiratory Infections | Lower respiratory tract infection

Datatype

boolean

Alias
UMLS CUI [1]
C0041912
UMLS CUI [2]
C0149725
2. emergency room treatment for asthma within 1 month or hospitalization for asthma within 3 months before visit 1
Beschrijving

Hospitalized or emergency room | Therapeutic procedure | Asthma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0004096
UMLS CUI [1,3]
C3475492
3. any evidence of infectious, oncologic, or other active pulmonary disease obtained by chest radiography within 12 months before visit 1
Beschrijving

Infectious Diseases | oncologic disorders | Lung diseases | Plain chest X-ray

Datatype

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C3853943
UMLS CUI [3,1]
C0024115
UMLS CUI [3,2]
C0039985
4. clinically significant, in the opinion of the investigator, hematological, liver, renal, heart, neurological disease, or other serious disease
Beschrijving

Hematological Disease | Liver diseases | Kidney Diseases | Heart Diseases | nervous system disorder

Datatype

boolean

Alias
UMLS CUI [1]
C0018939
UMLS CUI [2]
C0023895
UMLS CUI [3]
C0022658
UMLS CUI [4]
C0018799
UMLS CUI [5]
C0027765
UMLS CUI [6]
C2359476
5. hypersensitivity to any β2-agonist, sympathomimetic drug, leukotriene receptor antagonist or sophora tonkinensis radix rhizoma
Beschrijving

Hypersensitivity | Adrenergic beta-2 Receptor Agonists | Sympathomimetics | Leukotriene Antagonists

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2936789
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0039052
UMLS CUI [2,3]
C0020517
UMLS CUI [2,4]
C0595726
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C2816591
UMLS CUI [3,3]
C0020517
UMLS CUI [3,4]
C0242726
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0949790
6. clinically significant and uncontrolled psychiatric disease
Beschrijving

Mental disorders | Uncontrolled

Datatype

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0205318
7. history of drug or alcohol abuse
Beschrijving

Drug or alcohol abuse

Datatype

boolean

Alias
UMLS CUI [1]
C0237123
8. inhaled, oral or parenteral corticosteroids within 4 weeks before visit 1
Beschrijving

Inhaled steroids | Oral steroids | Parenteral steroids

Datatype

boolean

Alias
UMLS CUI [1]
C2065041
UMLS CUI [2]
C0001617
UMLS CUI [3,1]
C1272936
UMLS CUI [3,2]
C0001617
9. change of immunotherapy within 6 months before visit 1
Beschrijving

Immunotherapy | Changing

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0392747
10. administration of the antiasthma agent within 1 week of visit 1
Beschrijving

Anti-Asthmatic Agents

Datatype

boolean

Alias
UMLS CUI [1,1]
C0282556
UMLS CUI [1,2]
C1533734
11. administration of any other medication which may affect the course of asthma, or interact with sympathomimetic amines
Beschrijving

Pharmaceutical Preparations | Affecting | Asthma | Amines, Sympathomimetic

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0004096
UMLS CUI [2]
C0002509
12. participation in study using an experimental medication within 1 month before visit 1
Beschrijving

Study Subject Participation Status | Use of | Experimental drug

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
13. other ineligible subject in the opinion of the investigator
Beschrijving

patient not eligible

Datatype

boolean

Alias
UMLS CUI [1]
C3242266
Terug naar het begin van de pagina

Similar models

Eligibility Asthma NCT01907763

1 Formulieren
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01907763
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age | Gender
Item
1. male or eligible female subjects aged 15 years or more
boolean
C0001779 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Female | eligible
Item
2. a female is eligible if she is of:
boolean
Incapable | Pregnancy | Postmenopausal state
Item
non-child bearing potential (i.e., physiologically incapable of becoming pregnant), including any female who is at least 2 year after post- menopausal
boolean
C3831118 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
Childbearing Potential | Contraceptive methods
Item
child bearing potential and agrees to the acceptable contraceptive methods used consistently and correctly
boolean
C0700589 (UMLS CUI [1,1])
C0680240 (UMLS CUI [1,2])
Pregnancy test negative
Item
negative pregnancy test at screening
boolean
C0427780 (UMLS CUI [1])
Non-smoker | pack-years history
Item
3. non-smoker for at least 1 year, a pack history of ≤ 10 pack years
boolean
C0337672 (UMLS CUI [1,1])
C2230126 (UMLS CUI [1,2])
Persistent asthma | FEV1
Item
4. symptom of persistent asthma, as defined by the national institute of health (nih) 5.50 percent ≤ fev1 ≤ 80 percent predicted at screening visit (withholding inhaled, short acting
boolean
C3266628 (UMLS CUI [1,1])
C0748133 (UMLS CUI [1,2])
Adrenergic beta-Agonists
Item
ß-agonist for 6 hours)
boolean
C0001644 (UMLS CUI [1])
FEV1 | Reversibility
Item
6.fev1 reversibility ≥ 12 percent and 200 ml at 20-30 minutes after inhalation of a short acting
boolean
C0748133 (UMLS CUI [1,1])
C0449261 (UMLS CUI [1,2])
Adrenergic beta-Agonists | Salbutamol
Item
ß-agonist (salbutamol 2 puffs; 200㎍) at visit 1 or within 6 months before visit 1 7.capable of withholding salbutamol use for ≥ 6 hours prior to clinic visits 8.appropriately signed and dated informed consent has been obtained
boolean
C0001644 (UMLS CUI [1,1])
C0001927 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Upper Respiratory Infections | Lower respiratory tract infection
Item
1. active upper or lower respiratory tract infection within 3 weeks before visit 1
boolean
C0041912 (UMLS CUI [1])
C0149725 (UMLS CUI [2])
Hospitalized or emergency room | Therapeutic procedure | Asthma
Item
2. emergency room treatment for asthma within 1 month or hospitalization for asthma within 3 months before visit 1
boolean
C0087111 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C3475492 (UMLS CUI [1,3])
Infectious Diseases | oncologic disorders | Lung diseases | Plain chest X-ray
Item
3. any evidence of infectious, oncologic, or other active pulmonary disease obtained by chest radiography within 12 months before visit 1
boolean
C0009450 (UMLS CUI [1])
C3853943 (UMLS CUI [2])
C0024115 (UMLS CUI [3,1])
C0039985 (UMLS CUI [3,2])
Hematological Disease | Liver diseases | Kidney Diseases | Heart Diseases | nervous system disorder
Item
4. clinically significant, in the opinion of the investigator, hematological, liver, renal, heart, neurological disease, or other serious disease
boolean
C0018939 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0018799 (UMLS CUI [4])
C0027765 (UMLS CUI [5])
C2359476 (UMLS CUI [6])
Hypersensitivity | Adrenergic beta-2 Receptor Agonists | Sympathomimetics | Leukotriene Antagonists
Item
5. hypersensitivity to any β2-agonist, sympathomimetic drug, leukotriene receptor antagonist or sophora tonkinensis radix rhizoma
boolean
C0020517 (UMLS CUI [1,1])
C2936789 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0039052 (UMLS CUI [2,2])
C0020517 (UMLS CUI [2,3])
C0595726 (UMLS CUI [2,4])
C0020517 (UMLS CUI [3,1])
C2816591 (UMLS CUI [3,2])
C0020517 (UMLS CUI [3,3])
C0242726 (UMLS CUI [3,4])
C0020517 (UMLS CUI [4,1])
C0949790 (UMLS CUI [4,2])
Mental disorders | Uncontrolled
Item
6. clinically significant and uncontrolled psychiatric disease
boolean
C0004936 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Drug or alcohol abuse
Item
7. history of drug or alcohol abuse
boolean
C0237123 (UMLS CUI [1])
Inhaled steroids | Oral steroids | Parenteral steroids
Item
8. inhaled, oral or parenteral corticosteroids within 4 weeks before visit 1
boolean
C2065041 (UMLS CUI [1])
C0001617 (UMLS CUI [2])
C1272936 (UMLS CUI [3,1])
C0001617 (UMLS CUI [3,2])
Immunotherapy | Changing
Item
9. change of immunotherapy within 6 months before visit 1
boolean
C0021083 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
Anti-Asthmatic Agents
Item
10. administration of the antiasthma agent within 1 week of visit 1
boolean
C0282556 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
Pharmaceutical Preparations | Affecting | Asthma | Amines, Sympathomimetic
Item
11. administration of any other medication which may affect the course of asthma, or interact with sympathomimetic amines
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0004096 (UMLS CUI [1,3])
C0002509 (UMLS CUI [2])
Study Subject Participation Status | Use of | Experimental drug
Item
12. participation in study using an experimental medication within 1 month before visit 1
boolean
C2348568 (UMLS CUI [1])
patient not eligible
Item
13. other ineligible subject in the opinion of the investigator
boolean
C3242266 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial